Liu L, Burcher E
School of Physiology and Pharmacology, University of New South Wales, Sydney, Australia.
Naunyn Schmiedebergs Arch Pharmacol. 2001 Oct;364(4):305-13. doi: 10.1007/s002100100452.
Tachykinin receptors in chicken intestine were studied using radioligand binding and functional techniques. Mechanisms of tachykinin-induced contraction were also investigated. Binding of [125I]Bolton-Hunter substance P ([125I]BH-SP) to chicken ileal membranes was rapid, saturable, of high affinity and to a single population of binding sites with Kd 0.72 nM and Bmax 0.48 fmol/ wet weight tissue. The rank order of agonists competing for [125I]BH-SP binding sites was [Sar9]SP > [Arg3]SP (natural tachykinin in chickens) > SP > [Pro9]SP > or = NKA > eledoisin > [Sar9,Met(O2)11]SP >> [Lys5,MeLeu9,Nle10]-NKA(4-10) >> senktide, suggesting similarities to the mammalian NK1 receptor. The NK1 receptor antagonist CP 99994, and NK2 receptor antagonist SR 48968 were weak competitors while spantide, RP 67580, GR 82334, GR 94800 and MEN 11420 were ineffective. The radioligand [125I]NKA showed no specific binding to ileal membranes. The potency order of most tachykinins in contacting isolated ileal longitudinal segments was in good agreement with that obtained from competition binding studies. Contractions to [Arg3]SP, NKA and senktide were greatly reduced by tetrodotoxin, suggesting that neurally-mediated responses were primarily involved. [Arg3]SP and NKA acted mainly by increasing release of acetylcholine, prostaglandins and probably tachykinins. Responses to [Arg3]SP were virtually abolished by nifedipine but were unaffected by NK1 receptor antagonists. Senktide-induced contraction was inhibited by the NK3 receptor antagonist, SR 142801, but was unaffected by atropine or L-NAME. The study provides evidence for a tachykinin receptor with similarities to the NK1 receptor in the chicken small intestine. In addition, senktide may act on a receptor similar to the mammalian NK3 receptor.
利用放射性配体结合和功能技术对鸡肠道中的速激肽受体进行了研究。还研究了速激肽诱导收缩的机制。[125I]博尔顿-亨特物质P([125I]BH-SP)与鸡回肠膜的结合迅速、可饱和、具有高亲和力,且作用于单一的结合位点群体,解离常数(Kd)为0.72 nM,最大结合量(Bmax)为0.48 fmol/湿重组织。竞争[125I]BH-SP结合位点的激动剂的效价顺序为:[Sar9]SP > [Arg3]SP(鸡体内的天然速激肽)> SP > [Pro9]SP ≥ NKA > 伊索辛 > [Sar9,Met(O2)11]SP >> [Lys5,MeLeu9,Nle10]-NKA(4 - 10) >> 森克肽,提示其与哺乳动物NK1受体有相似性。NK1受体拮抗剂CP 99994和NK2受体拮抗剂SR 48968是弱竞争者,而泮托肽、RP 67580、GR 82334、GR 94800和MEN 11420无效。放射性配体[125I]NKA与回肠膜无特异性结合。大多数速激肽在使离体回肠纵行肌收缩方面的效价顺序与竞争结合研究所得结果高度一致。河豚毒素可显著减弱对[Arg3]SP、NKA和森克肽的收缩反应,提示主要涉及神经介导的反应。[Arg3]SP和NKA主要通过增加乙酰胆碱、前列腺素以及可能还有速激肽的释放起作用。硝苯地平可几乎完全消除对[Arg3]SP的反应,但不受NK1受体拮抗剂的影响。森克肽诱导的收缩可被NK3受体拮抗剂SR 142801抑制,但不受阿托品或L - 精氨酸甲酯的影响。该研究为鸡小肠中存在与NK1受体相似的速激肽受体提供了证据。此外,森克肽可能作用于一种与哺乳动物NK3受体相似的受体。